CN104208267A - Chinese medicine or health care product for treating postpartum anemia - Google Patents

Chinese medicine or health care product for treating postpartum anemia Download PDF

Info

Publication number
CN104208267A
CN104208267A CN201410500733.1A CN201410500733A CN104208267A CN 104208267 A CN104208267 A CN 104208267A CN 201410500733 A CN201410500733 A CN 201410500733A CN 104208267 A CN104208267 A CN 104208267A
Authority
CN
China
Prior art keywords
parts
anemia
chinese medicine
health care
care product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410500733.1A
Other languages
Chinese (zh)
Other versions
CN104208267B (en
Inventor
张永胜
王萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410500733.1A priority Critical patent/CN104208267B/en
Publication of CN104208267A publication Critical patent/CN104208267A/en
Application granted granted Critical
Publication of CN104208267B publication Critical patent/CN104208267B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to Chinese medicine or a health care product for treating postpartum anemia. The Chinese medicine or the health care product is prepared by the following raw medicinal materials of, by weight, 12 parts of prepared rehmannia roots, 9 parts of Indian buead, 15 parts of Chinese dates, 10 parts of hawthorn, 8 parts of flatstem milkvetch seeds, and 6 parts of ginseng leaves. According to experiments, the Chinese medicine or the health care product is capable of safely and effectively treating postpartum anemia.

Description

A kind of Chinese medicine or health product that are used for the treatment of postpartum anemia
Technical field
The present invention relates to a kind of Chinese medicine or health product, be specifically related to a kind of Chinese medicine or health product that are used for the treatment of postpartum anemia.
Background technology
Anemia belongs to the clinical frequently-occurring disease of blood system, especially with women, child. and old people is common.The following child morbidity rate of China 7 years old is up to 64%, thus FAO (Food and Agriculture Organization of the United Nation) and World Health Organization (WHO) anemia is decided to be worldwide, one of developing country's four large food deficiency diseases particularly.According to statistics, China's anemia incidence rate is up to 15%~20% at present, and the whole nation approximately has 200,000,000 people to suffer from anemia and muscular dystrophy, and wherein women, child are group of people at high risk.Children anemia rate is in 25% left and right, and man's anemia rate is in 10% left and right, and women anemia rate is in 20% left and right, and anemia of pregnant woman's anemia rate is up to 35%.Birth process severe loss of blood, is easy to cause new mother's anemia, and anemia seriously can have influence on new mother's physical recovery and baby's nutrient health.Postpartum anemia can make people's malaise, inappetence, resistance decline, and can also cause the symptoms such as uncomfortable in chest, nervous, and may produce many complication, so once quilt is made a definite diagnosis anemia should treat in time when serious.
Medical material involved in the present invention is all recorded in < < Chinese Pharmacopoeia > >.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine or health product that are used for the treatment of postpartum anemia, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing postpartum anemia.
In order to achieve the above object, the present invention is by the following technical solutions:
The Chinese medicine or the health product that are used for the treatment of postpartum anemia, is characterized in that, it is that raw medicinal material by following weight proportion is prepared from: 12 parts of Radix Rehmanniae Preparata, 9 parts, Poria, 15 parts, Fructus Jujubae, 10 parts of Fructus Crataegis, 8 parts of Semen Astragali Complanatis, 6 parts of Folium Ginseng.
The selected medical material property of medicine of the present invention is gentle, and formula is taken safety, and healing postpartum anemia effect is remarkable, and puerpera's acceptance is good.There is certain promotional value.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
Inventor collects postpartum anemia puerpera totally 116 examples in December, 2010 ~ 2013 altogether between year June, all cases all meet the diagnostic criteria of adult female's trophism and hemorrhagic anemia.At 22 years old to 36 years old age, wherein natural labor 55 examples, cut open palace and produce 61 examples.Be divided at random treatment group 60 example and matched group 56 examples.Two groups of patients are in age, the state of an illness. and the aspect difference not statistically significants such as nutriture, have comparability.
2, test method
2.1 Therapeutic Method
The capsule that the oral the present invention for the treatment of group makes according to specific embodiment 3, every bu is taken for twice sooner or later.1 month course for the treatment of.
In the oral benefit of matched group, the funeral of hemopoietic glue, takes according to its description.1 month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
The diagnostic criteria of adults women's anemia: red blood cell count(RBC) <3.5 * 10 12/ L, hemoglobin <110g/L.
3.2 therapeutic outcome
Routine anemia recovery of lying-in woman 57 examples for the treatment of group 60, cure rate 95%; Routine anemia recovery of lying-in woman 48 examples of matched group 56, cure rate 87.5%.During treatment, mother and baby is showed no obvious adverse reaction.
It is safe and effective that visible the present invention is used for the treatment of postpartum anemia, has the value of applying.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
Specific embodiment 1
Take: 12 grams of Radix Rehmanniae Preparata, 9 grams, Poria, 15 grams, Fructus Jujubae, 10 grams of Fructus Crataegis, 8 grams of Semen Astragali Complanatis, 6 grams of Folium Ginseng; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 100 grams, encapsulates, and must meet the decoct of one day consumption of normal adult.
Be used for the treatment of postpartum anemia.Oral, 1 dose of every day.
Specific embodiment 2
Take: 12 grams of Radix Rehmanniae Preparata, 9 grams, Poria, 15 grams, Fructus Jujubae, 10 grams of Fructus Crataegis, 8 grams of Semen Astragali Complanatis, 6 grams of Folium Ginseng; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, pack, must meet the powder of one day consumption of normal adult.
Be used for the treatment of postpartum anemia.Warm boiled water, every bu morning, noon and afternoon take for three times.
Specific embodiment 3
Take: 12 grams of Radix Rehmanniae Preparata, 9 grams, Poria, 15 grams, Fructus Jujubae, 10 grams of Fructus Crataegis, 8 grams of Semen Astragali Complanatis, 6 grams of Folium Ginseng; Add 6 times of water gagings, decoct 3 times, decoct 1 hour at every turn, merge decoction liquor, concentrated, dry, incapsulate shell, must meet the capsule of one day consumption of normal adult.
Be used for the treatment of postpartum anemia.Warm water delivery service, every bu is taken for twice sooner or later.

Claims (1)

1. the Chinese medicine or the health product that are used for the treatment of postpartum anemia, is characterized in that, it is that raw medicinal material by following weight proportion is prepared from: 12 parts of Radix Rehmanniae Preparata, 9 parts, Poria, 15 parts, Fructus Jujubae, 10 parts of Fructus Crataegis, 8 parts of Semen Astragali Complanatis, 6 parts of Folium Ginseng.
CN201410500733.1A 2014-09-26 2014-09-26 A kind of Chinese medicine or health product being used for the treatment of postpartum anemia Expired - Fee Related CN104208267B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410500733.1A CN104208267B (en) 2014-09-26 2014-09-26 A kind of Chinese medicine or health product being used for the treatment of postpartum anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410500733.1A CN104208267B (en) 2014-09-26 2014-09-26 A kind of Chinese medicine or health product being used for the treatment of postpartum anemia

Publications (2)

Publication Number Publication Date
CN104208267A true CN104208267A (en) 2014-12-17
CN104208267B CN104208267B (en) 2016-03-23

Family

ID=52090440

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410500733.1A Expired - Fee Related CN104208267B (en) 2014-09-26 2014-09-26 A kind of Chinese medicine or health product being used for the treatment of postpartum anemia

Country Status (1)

Country Link
CN (1) CN104208267B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083541A (en) * 2013-02-02 2013-05-08 徐美玲 Drug for treating anemia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083541A (en) * 2013-02-02 2013-05-08 徐美玲 Drug for treating anemia

Also Published As

Publication number Publication date
CN104208267B (en) 2016-03-23

Similar Documents

Publication Publication Date Title
CN100493578C (en) Chinese medicine composition for treating thin body and delicate constitution, and preparing method
CN102266484B (en) Pueraria wine capable of preventing and treating cardiovascular and cerebrovascular diseases as well as preparation method and application thereof
CN105362776B (en) A kind of Chinese medicine composition for treating hyperthyroidism, preparation method and applications
CN104208267B (en) A kind of Chinese medicine or health product being used for the treatment of postpartum anemia
CN102908396A (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN102698099A (en) Pill for treating diabetes mellitus
CN102488751A (en) Chinese medicinal preparation for treating infantile diarrhea
CN106334065A (en) Edible and medicinal traditional Chinese medicine formula used for treating gynecological diseases and having beauty effect and production process
CN106173128A (en) A kind of chocolate with anti-fatigue effect and preparation method thereof
CN102327410B (en) Traditional Chinese medicine composition for treating epigastric fullness
CN105362629A (en) Female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae and preparation method of female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae
CN102836315A (en) Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof
CN112336802B (en) Traditional Chinese medicine composition for improving glycolipidosis metabolism of diabetes and application thereof
CN102488807A (en) Medicine for treating asthma
CN104189443A (en) Traditional Chinese medicine or health care product for treating cyasma
CN104491475A (en) Prevention and healthcare traditional Chinese medicine preparation and preparation method thereof
CN104383247A (en) Traditional Chinese medicine for treating phthisis
CN103877506A (en) Medicament for treating epilepsy
CN102091260B (en) Chinese medicinal composition for treating bronchitis
CN104147501A (en) Traditional Chinese medicine for treating zinc deficiency, and preparation method thereof
CN102552790B (en) Medicament for stopping vomit after radiography
CN104042776A (en) Traditional Chinese medicine for treating chloasma with irregular menstruation
CN103584097A (en) Preparation and functions of longevity-promoting and health-care cream
CN102813825A (en) Nine-medicine hemorrhoid pill

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160323

Termination date: 20200926

CF01 Termination of patent right due to non-payment of annual fee